SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 24, 16:01
3025.25
-5.45 (-0.18%)
VOLUME 23,260
LIVE
NSE
May 24, 16:01
3025.15
-4.65 (-0.15%)
VOLUME 159,174
Earnings News on Dr Reddys Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
New launches to drive growth in second quarter: Dr Reddy's 

8.53 pm | 12 May 2016 |  Source: CNBC-TV18

There are approvals pending, but not from its Srikakulam plant. But improving quality checks at pharma's plants would be a high priority, says GV Pras...

Venezuelan write-offs hit Dr Reddy's Q4 numbers:Experts 

2.44 pm | 12 May 2016 |  Source: CNBC-TV18

Disappointing performance in the topline and ongoing currency issues have hurt Q4 numbers of the pharma company," says Mayuresh Joshi of Angel Broking...

Dr Reddy's Q4 net tanks 86%, hit by one-time Venezuela write-off 

1.53 pm | 12 May 2016 |  Source: Moneycontrol.com

Dr Reddy's Lab fourth quarter earnings were hurt by one-time Venezuela write-off. The drug major's net profit fell 86 percent at Rs 74.6 crore in Janu...

Dr Reddy's Q4 profit may rise 6%, warning letters resolution key 

11.45 am | 12 May 2016 |  Source: Moneycontrol.com

During the period, EBITDA may grow 11.2 percent to Rs 897 crore versus Rs 806.4 crore while margins may stand at 23 percent versus 21 percent....

Dr Reddys Labs consolidated Dec '15 sales at Rs 3,967.90 crore

9.27 am | 10 Feb 2016 |  Source: Moneycontrol.com

Dr Reddys Laboratories has reported a consolidated total income from operations of Rs 3,967.90 crore and a net profit of Rs 579.20 crore for the quart...

See huge opportunity in Venezuela; US supply not restricted: DRL 

8.00 pm | 09 Feb 2016 |  Source: CNBC-TV18

Saumen Chakraborty, CFO, Dr Reddy's, says the company has been calibrating sales in Venezuala where the market and capacity is huge....

Dr Reddy's Q3 net at Rs 579 cr, India biz grows 34% 

2.02 pm | 09 Feb 2016 |  Source: Moneycontrol.com

Revenue of India business grew 34 percent at Rs 580 crore in Q3 versus Rs 433 crore (YoY)....

Dr Reddy's Q3 profit seen up 13%, Russia & CIS may hurt revenue 

12.42 pm | 08 Feb 2016 |  Source: CNBC-TV18

Revenue is seen rising 4.3 percent to Rs 4,007 crore in quarter ended December 2015 compared to Rs 3,843 crore in corresponding quarter of last fiscal...

1
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.